Precise execution

MC Services is...

Client News



… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.


read more



MC Services sponsors Best Technology Award at the 2017 European Mediscience Awards

MC Services is proud to contribute to this year’s European Mediscience Awards as a sponsor of the Best Technology Award, for innovative technology that is well funded and capable of significant commercial success.

Nominations for the 2017 Mediscience Awards are open – it’s time to get voting!

Learn more



Newron Pharmaceuticals and MorphoSys @ LaBiotech Refresh Afterwork Meetup

On April 3rd LaBiotech is hosting the first Meeting of its newly launched monthly Refresh Afterwork Meetup Series. This time, fireside chats will feature Stefan Weber, CEO of Newron Pharmaceuticals, and Simon Moroney, CEO and co-founder of Morphosys.


When:  April 3rd

Where:  Munich, IZB Residence CAMPUS AT HOME


18:30 - 19:00: Welcoming

19:00 - 19:30: 1st Fireside Chat – Stefan Weber, CEO - Newron

19:30 - 20:00: 2nd Fireside Chat – Simon Moroney, CEO & Co-founder – Morphosys

20:00 - 21:00: Enjoy beers from Munich and networking


Free Entry

Learn more

PAION reports positive headline data in U.S. clinical safety trial of remimazolam in high-risk patients undergoing colonoscopy


Newron presents encouraging detailed results of its Phase IIa study with Evenamide in patients with schizophrenia


MorphoSys's CSO Marlies Sproll Takes Temporary Leave Markus Enzelberger to Serve as Interim CSO (news with additional features)


Medigene AG: Medigene revises collaboration with Mitsui Norin


Medigene AG: Announces target and outlines design for its first clinical trial in TCR cancer immunotherapy


Medigene AG: Medigene publishes its 2016 annual report and outlook for 2017


Probiodrug AG to Publish its Full Year 2016 Results on 30 March 2017 


2016 annual results


SYGNIS anounces change in guarantee for Spanish government soft loans


FDA approves Xadago® (safinamide) for Parkinson’s disease (PD) patients


RedHill Biopharma Announces First Patient Dosed in the Open-Label Extension Study to the Phase III Study with RHB-104 for Crohn's Disease


Notice of Preliminary Results


4SC-202 – a promising combination partner for cancer treatmen